Drug Shortage Report for VIMOVO
| Report ID | 165617 |
| Drug Identification Number | 02361728 |
| Brand name | VIMOVO |
| Common or Proper name | naproxen / esomeprazole |
| Company Name | XEDITON PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
| Strength(s) | 20MG 500MG |
| Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 tablets |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-22 |
| Estimated end date | 2022-12-31 |
| Actual end date | 2022-12-20 |
| Shortage status | Resolved |
| Updated date | 2022-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2020 WINSTON PARK DRIVE OAKVILLE, ONTARIO CANADA L6H 6X7 |
| Company contact information | george.gafrey@xediton.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2022-12-21 | English | Compare |
| v10 | 2022-12-20 | French | Compare |
| v9 | 2022-12-20 | English | Compare |
| v8 | 2022-11-30 | French | Compare |
| v7 | 2022-11-30 | English | Compare |
| v6 | 2022-10-27 | French | Compare |
| v5 | 2022-10-27 | English | Compare |
| v4 | 2022-09-30 | French | Compare |
| v3 | 2022-09-30 | English | Compare |
| v2 | 2022-07-28 | French | Compare |
| v1 | 2022-07-28 | English | Compare |
Showing 1 to 11 of 11